Pharmaceutical Technology The leading site for news and procurement in the pharmaceutical industry
- JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lilly’s low revenue forecastby GlobalData Healthcare on January 16, 2025 at 9:57 pm
Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company’s co-CEO.
- JP Morgan 2025: Radiopharmaceuticals M&A fuels Telix’s busy yearby Frankie Fattorini on January 16, 2025 at 7:40 pm
The radiopharmaceutical developer expanded its reach, acquiring R&D, isotope production, manufacturing, and distribution.
- European supergroup launches to tackle diversity in clinical trialsby Joshua Silverwood on January 16, 2025 at 4:41 pm
The new pan-European group of 73 regulators, companies and trial sites is backed by €66.8m in funding with a six-year goal.
- Santhera launches DMD therapy in the UK following NICE nodby Jenna Philpott on January 16, 2025 at 4:16 pm
Santhera Pharmaceuticals has started launch preparations for its DMD drug Agamree (vamorolone) in the UK, after a recommendation from NICE.
- Meridian Medical wins $129m US gov contract for nerve agent antidote supplyby Ross Law on January 16, 2025 at 3:59 pm
Meridian Medical Technologies has won a new contract worth up to $129m from the US for the supply of its DuoDote nerve agent antidote autoinjectors to the SNS.
OncLive articles OncLive articles
- FDA Approves Incyte and Syndax’s Niktimvo for Chronic Graft-Versus-Host Disease in 9 and 22 mg Vial Sizeson January 16, 2025 at 8:15 pm
Niktimvo marks the first FDA-approved therapy targeting CSF-1R to address inflammation and fibrosis in chronic graft-versus-host disease.
- AD04-13 Study Highlights Consistent Bioavailability and Safety for Alcohol Use Disorder Treatmenton January 16, 2025 at 7:00 pm
Cary Claiborne, CEO, Adial Pharmaceuticals, discusses promising results of the AD04-13 study in patients with Alcohol Use Disorder
- FDA Approves Eli Lilly’s Omvoh for Crohn Diseaseon January 16, 2025 at 5:17 pm
Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and endoscopic response rates in patients with Crohn disease.
- Cigna Expands Access to Fertility and Family-Building Benefitson January 16, 2025 at 2:30 pm
A new offering in collaboration with Progyny, Inc makes fertility/family-building services more accessible and equitable.
- Engaging Patients: Why Pharma’s Direct-to-Patient Approach Should Be Applaudedon January 16, 2025 at 1:00 pm
Physicians remain central even as DTP programs are implemented.
Endpoints News Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
- Roche’s cardiometabolic chief warns against weight loss ‘obsession’ with GLP-1sby Max Bayer on January 16, 2025 at 9:00 pm
The rise of GLP-1s has made treating obesity one of the largest market opportunities in history. It also has reinforced a detrimental relationship between physical health and size, according to one pharma executive. “Unfortunately, our …
- Departing FDA commissioner: ‘We’re losing the battle on misinformation’by Zachary Brennan on January 16, 2025 at 8:59 pm
Rob Califf officially ends his tenure as FDA commissioner on Monday, but in his final media event, he stressed that the US is still struggling to fight misinformation online. “I’m afraid that my conclusion right …
- Teva says it has a ‘unique position’ in latest IRA challengeby Nicole DeFeudis on January 16, 2025 at 8:20 pm
Teva is the latest drugmaker to file suit against Medicare negotiations. But unlike other companies that have challenged the inclusion of their drugs in negotiations, Teva says its case is unique. The drugmaker is not …
- HHS blasts Boehringer’s drug price case, reveals new details on Jardiance talksby Nicole DeFeudis on January 16, 2025 at 8:09 pm
HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its legal challenge to the process. Voluntariness was a key factor in the lower court’s decision to toss …
- Shionogi lands $375M from HHS to develop preventive drug for Covid-19by Alexis Kramer on January 16, 2025 at 8:05 pm
After seeing its Covid-19 drug fail in a Phase 3 trial last year, Shionogi on Thursday won a $375 million award from HHS to develop a preventive drug for the disease. The drug is aimed …
Pharmaceutical Technology articles Pharmaceutical Technology articles
- Almac Sciences Invests £500K in Spectroscopy Lab Instrumentationon January 16, 2025 at 10:53 pm
This investment is additional to and separate from £11 million that was announced in the fall of 2024 for creating new jobs and expanding Almac’s global analytical services capabilities.
- Pharmapack Reports on Key Trends for 2025on January 16, 2025 at 3:19 pm
Pharmapack identifies biologic approvals, drug delivery advancements, GLP-1 generics, and the return of funding flow as drivers for a record year in 2025.
- Lyndra, Thermo Fisher to Partner on R&D for Long-Acting Oral Therapieson January 15, 2025 at 8:55 pm
The collaboration will leverage Thermo Fisher’s Accelerator Drug Development stable of solutions, which was launched in the fall of 2024.
- Behind the Headlines: 2025 Wish Liston January 15, 2025 at 1:00 pm
Vanessa Almendro, Elliot Berger, Benjamin McCloud, and Turna Ray go behind the headlines to discuss their ‘wish list’ for the progression of trends in the bio/pharmaceutical industry.
- Lonza and Iconovo Team Up on Intranasal Biologic Candidateon January 15, 2025 at 1:00 pm
Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.
Pharmaceutical Processing World The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
- WuXi to sell Irish vaccine site to Merck ahead of potential U.S. law limiting Chinese biotech businessby Sean Whooley on January 6, 2025 at 9:20 pm
Merck agreed to acquire a vaccine manufacturing facility in Ireland from WuXi, the Irish Foreign Direct Investment Arm (IDA) announced today. IDA Ireland said the move comes as part of long-term plans in Ireland for Merck Sharp & Dohme (MSD), Merck’s Ireland business. The acquisition of the facility, located in Dundalk, brings an investment of… The post WuXi to sell Irish vaccine site to Merck ahead of potential U.S. law limiting Chinese biotech business appeared first on Pharmaceutical Processing World.
- PharmaEssentia commits to interferon therapy production amid shortageby Sean Whooley on January 6, 2025 at 8:10 pm
PharmaEssentia has reaffirmed its commitment to creating access to critical interferon therapies amid a reported global shortage. The Burlington, Massachusetts-based company noted a recent reported shortage of Pegasys (peginterferon alfa-2a). With concerns growing over drug shortages for other therapies, the company said its established cGMP manufacturing network and patient-focused approach can help it meet the… The post PharmaEssentia commits to interferon therapy production amid shortage appeared first on Pharmaceutical Processing World.
- African Union vaccine initiative receives $45Mby Sean Whooley on January 2, 2025 at 5:02 pm
An African Union effort to strengthen public health and improve vaccine access in Africa has received a $45 million financing package. The U.S. International Development Finance Corporation, the African Development Bank and the International Finance Corporation (IFC) jointly announced the package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). This agreement underscores… The post African Union vaccine initiative receives $45M appeared first on Pharmaceutical Processing World.
- Mary Marcus appointed CEO of NewAge Industriesby Pharmaceutical Processing on December 19, 2024 at 4:59 pm
Press release: Southampton, PA – NewAge Industries, Inc., parent company of AdvantaPure™ and NewAge Performance Products, a global leader in fluid transfer systems solutions for the biopharma and industrial markets, is pleased to announce the appointment of Mary Marcus to the position of CEO. “Since her arrival in 2008, Mary has been a vital part… The post Mary Marcus appointed CEO of NewAge Industries appeared first on Pharmaceutical Processing World.
- Lilly gets nod to market locally manufactured insulin in Egyptby Sean Whooley on December 17, 2024 at 8:38 pm
Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership with Eva Pharma. The companies launched their collaboration in 2022 to deliver a sustainable supply of high-quality, affordable human and analog insulin. It wants to bring insulin to at least 1 million people annually living with diabetes in low- to… The post Lilly gets nod to market locally manufactured insulin in Egypt appeared first on Pharmaceutical Processing World.